Just In: Chinese Company Produces COVID-19 Vaccine – Promising Results

Just In: Chinese Company Produces COVID-19 Vaccine – Promising Results

After all the bad and disturbing news that’s been popping up online about the coronavirus and potential vaccines, some pretty promising news is finally out.

It’s been just revealed that the Chinese managed to create a vaccine against the novel coronavirus that’s showing promising results.

Global Times reported that an institute of biological products that’s located in Beijing and affiliated with the China National Pharmaceutical Group (Sinopharm) announced on Sunday that it had achieved positive results for a COVID-19 vaccine candidate that it created. 

Successful COVID-19 vaccine 

This development came as the global number of confirmed patients eventually surpassed 10 million as of 6:30 pm Sunday (Beijing time).

“Three of the four inactivated COVID-19 vaccines developed in China evoked positive immune responses in Phase I and II clinical trials, indicating that China has made great progress in the research and develops ent (R&D) of this type of vaccine,” experts said as cited by the online publication mentioned above. 

The Beijing institute, which is under the Sinopharm China National Biotec Group (CNBG), sent a statement to the Global Times which revealed that “all 1,120 volunteers in the first and second phase clinical trials successfully produced high-titer antibodies against COVID-19 after accepting two doses of the vaccine.”

Mass production of inactivated vaccines face problems 

It’s also important to mention that there’s another institute under CNBG in Wuhan, which revealed back on June 16 the results of the Phase I and II clinical trials of a vaccine that they developed – this offered more vital data for CNBG’s research of inactivated COVID-19 vaccines, read the statement.

On the other hand, mass production of inactivated vaccines is faced with some issues regarding insufficient capacity, according to experts:

“Each person needs two doses of the inactivated vaccine to evoke an immune response, and 200 million doses would only meet the immunization needs of 100 million people. This is still far from enough for China and the world at a time when vaccines are urgently needed,” Tao Lina, a Shanghai-based vaccine expert, told the Global Times the other day. 

In other news, it’s been revealed that the danger of coronavirus could pass soon, according to the latest reports.

Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.